Tag: Prescription Drugs
Review: Low Risk of Birth Defects With Ondansetron Exposure
Ondansetron-exposed neonates may have small increase in incidence of cardiac abnormalities
Computerized Order Set Aids Prescribing in COPD Exacerbations
Increase in percentage of patients receiving all recommended pharmacologic therapies
Optimized Tx Linked to Lasting Pain Relief in Chronic Pancreatitis
Significant pain relief achieved in 84.7 percent of patients at one-year follow-up; most with medical tx
Coalition Calls for Changes to Hospital Pain Assessments
Petition asks government to release proposal for a new pain questionnaire for hospital patients
CV Risk Not Significantly Different for GLP-1 Receptor Agonists
Findings based on large study in real-world, head-to-head comparison of other drugs
Androgen Deprivation Tx for Prostate CA Tied to Depression
Researchers find 23 percent increased risk compared to men who received other treatments
Doctors Can Be Misled About FDA ‘Breakthrough’ Drug Designation
Many believe meds supported by stronger evidence than the law requires to achieve designation
Guidance Issued on Use of Direct Oral Anticoagulants in Obese
DOAC use not recommended for patients with BMI >40 kg/m² and weight >120 kg
Exenatide Twice Daily Deemed Efficacious Across BMI Ranges
Significant weight loss with exenatide across BMI ranges; weight increased with comparators
Progesterone Attenuates Drug-Induced QT Interval Lengthening
Findings in healthy females who received progesterone or placebo for seven days
